Cargando…

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

BACKGROUND: Despite concerns that patients with liver transplants might be at increased risk of adverse outcomes from COVID-19 because of coexisting comorbidities and use of immunosuppressants, the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on this patient group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, Gwilym J, Marjot, Thomas, Cook, Jonathan A, Aloman, Costica, Armstrong, Matthew J, Brenner, Erica J, Catana, Maria-Andreea, Cargill, Tamsin, Dhanasekaran, Renumathy, García-Juárez, Ignacio, Hagström, Hannes, Kennedy, James M, Marshall, Aileen, Masson, Steven, Mercer, Carolyn J, Perumalswami, Ponni V, Ruiz, Isaac, Thaker, Sarang, Ufere, Nneka N, Barnes, Eleanor, Barritt, Alfred S, Moon, Andrew M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455160/ https://www.ncbi.nlm.nih.gov/pubmed/32866433 http://dx.doi.org/10.1016/S2468-1253(20)30271-5

Ejemplares similares

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
por: Marjot, Thomas, et al.
Publicado: (2021)

COVID-19 and liver transplantation: the jury is still out – Authors' reply
por: Webb, Gwilym J, et al.
Publicado: (2021)

Determining risk factors for mortality in liver transplant patients with COVID-19
por: Webb, Gwilym J, et al.
Publicado: (2020)

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients
por: Webb, Gwilym J., et al.
Publicado: (2021)

Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study
por: Kim, Donghee, et al.
Publicado: (2021)

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases
por: Adeniji, Nia, et al.
Publicado: (2021)

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
por: Baldelli, Luke, et al.
Publicado: (2023)

Murine Models of Alcohol Consumption: Imperfect but Still Potential Source of Novel Biomarkers and Therapeutic Drug Discovery for Alcoholic Liver Disease
por: Alharshawi, Khaled, et al.
Publicado: (2021)

COVID-19 and liver disease: mechanistic and clinical perspectives
por: Marjot, Thomas, et al.
Publicado: (2021)

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination
por: Moon, Andrew M., et al.
Publicado: (2021)

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
por: Marjot, Thomas, et al.
Publicado: (2021)

Innovations in Hepatitis C Screening and Treatment
por: Patel, Arpan A., et al.
Publicado: (2020)

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
por: Adeniji, Nia, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with autoimmune hepatitis
por: Marjot, Thomas, et al.
Publicado: (2021)

A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform()()
por: Tomimaru, Yoshito, et al.
Publicado: (2019)

Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma
por: Kim, Miran, et al.
Publicado: (2022)

HBV screening among West Africans living in the US: Influences of stigma, health literacy, and self-efficacy
por: Perumalswami, Ponni V, et al.
Publicado: (2023)

Alcohol Consumption Accumulation of Monocyte Derived Macrophages in Female Mice Liver Is Interferon Alpha Receptor Dependent
por: Alharshawi, Khaled, et al.
Publicado: (2021)

Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes
por: Vandromme, Maxence, et al.
Publicado: (2020)

Cost and value in liver disease guidelines: 2011–2022
por: Aby, Elizabeth S., et al.
Publicado: (2023)

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
por: Dhanasekaran, Renumathy, et al.
Publicado: (2012)

Chinese Skullcap in Move Free Arthritis Supplement Causes Drug Induced Liver Injury and Pulmonary Infiltrates
por: Dhanasekaran, Renumathy, et al.
Publicado: (2013)

COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter
por: Lee, Brian T., et al.
Publicado: (2020)

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
por: Dhanasekaran, Renumathy, et al.
Publicado: (2016)

Antibiotic prophylaxis in palliative patients with cirrhosis: Stewardship or gatekeeping?
por: Haddadin, Yazan, et al.
Publicado: (2023)

Rare Case of Adult Undifferentiated (Embryonal) Sarcoma of the Liver Treated with Liver Transplantation: Excellent Long-Term Survival
por: Dhanasekaran, Renumathy, et al.
Publicado: (2012)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
por: Hannaford, Alisse, et al.
Publicado: (2017)

The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis
por: Kochar, Bharati, et al.
Publicado: (2022)

Fatal COVID‐19 in a Patient with End‐Stage Liver Disease Wait‐Listed for Liver Transplantation: An Evidence‐Based Review of COVID‐19 Screening Modalities Prior to Transplant
por: Rhee, Yoona, et al.
Publicado: (2020)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021)

Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment
por: Talal, Andrew H., et al.
Publicado: (2023)

Review article: current and emerging therapies for the management of cirrhosis and its complications
por: Tapper, Elliot B., et al.
Publicado: (2022)

Therapeutic vaccination for treatment of chronic hepatitis B
por: Cargill, Tamsin, et al.
Publicado: (2021)

Physical activity in US Blacks: a systematic review and critical examination of self-report instruments
por: Wolin, Kathleen Y, et al.
Publicado: (2010)

Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C
por: Perumalswami, Ponni V., et al.
Publicado: (2022)

Proteomic Profiling of Early Chronic Pulmonary Hypertension: Evidence for Both Adaptive and Maladaptive Pathology
por: Aziz, Abdulhameed, et al.
Publicado: (2015)

Modification of the diabetes prevention program for the treatment of nonalcoholic fatty liver disease: A pilot study
por: Hershman, Melissa, et al.
Publicado: (2022)

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases
por: Cargill, Tamsin, et al.
Publicado: (2021)

Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease
por: Magdaleno, Fernando, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lh37oebahq1jgakaoqgrbifgiv